Table 2.
Direct medical costs for patients with Ischaemic heart disease, Ischaemic and Haemorrhagic stroke and Hypertensive heart disease stratified by resource use for the two study hospitals
IHD n = 92 |
I-stroke n = 317 |
H-stroke n = 193 |
HHD n = 248 |
Overall N = 850 |
|
---|---|---|---|---|---|
Consultation | |||||
Mean (SD) | 6300 (5200) | 13,700 (9800) | 10,400 (7300) | 7400 (7400) | 10,300 (8700) |
[11.4 (9.4)] | [24.8 (17.7)] | [18.8 (13.2)] | [13.4 (13.4)] | [18.6 (15.7)] | |
Median (25th – 75th percentile) | 3500 (3500 – 7000) | 7000 (7000 – 21,000) | 7000 (7000 – 14,000) | 7000 (3500 – 7000) | 7000 (3500 – 14,000) |
[6.3 (6.3–12.7)] | [12.7 (12.7–38.0)] | [12.7 (12.7–25.3)] | [12.7 (6.3–12.7)] | [12.7 (6.3–25.3)] | |
Sum (% of total costs) | 577,500 (0.5) | 4,336,500 (1.5) | 2,009,000 (1.3) | 1,841,000 (1.9) | 8,764,000 (1.2) |
[1045.4] | [7849.7] | [3636.6] | [3332.5] | [15,864.2] | |
Laboratory tests | |||||
Mean (SD) | 96,300 (58,700) | 111,000 (74,300) | 100,300 (80,900) | 102,700 (109,600) | 104,500 (86,000) |
[174.3 (106.3)] | [200.9 (134.5)] | [181.5 (146.4)] | [185.9 (198.4)] | [189.1 (155.6)] | |
Median (25th – 75th percentile) | 67,700 (63,400–131,300) | 103,900 (55,000–144,900) | 82,100 (49,700–126,200) | 58,300 (20,300 – 150,400) | 85,800 (41,100 – 140,800) |
[122.5 (114.7–237.7)] | [188.0 (99.5–262.3)] | [148.6 (89.9–228.4)] | [105.5 (36.7–272.2)] | [155.3 (74.4–254.8)] | |
Sum (% of total costs) | 8,856,500 (6.9) | 34,646,800 (11.7) | 19,258,600 (12.2) | 24,742,700 (25.9) | 87,504,600 (12.9) |
[16,031.6] | [62,715.9] | [34,860.9] | [44,788.0] | [158,396.5] | |
Imaging & procedures | |||||
Mean (SD) | 1,072,000 (1,356,000) | 193,300 (115,600) | 192,000 (317,700) | 74,800 (124,900) | 262,000 (575,600) |
[1940.4 (2454.5)] | [349.9 (209.2)] | [347.5 (575.1)] | [135.4 (226.1)] | [474.2 (1041.9)] | |
Median (25th – 75th percentile) | 675,000 (61,300 – 2,700,000) | 176,000 (90,000 – 266,000) | 143,100 (75,000 – 200,800) | 50,800 (30,000 – 71,300) | 125,800 (50,800 – 229,300) |
[1221.8 (110.9–4887.4)] | [318.6 (162.9–481.5)] | [259.0 (135.7–363.4)] | [91.9 (54.3–129.1)] | [227.7 (91.9–415.1)] | |
Sum (% of total costs) | 98,623,800 (76.8) | 58,582,300 (19.8) | 34,941,300 (22.2) | 16,374,500 (17.2) | 208,521,900 (30.8) |
[178,524.0] | [106,042.8] | [63,249.0] | [29,640.3] | [377,456.2] | |
Medication | |||||
Mean (SD) | 188,200 (191,900) | 332,800 (238,900) | 291,100 (221,700) | 166,100 (118,500) | 258,000 (213,400) |
[340.6 (347.3)] | [602.4 (432.4)] | [526.9 (401.3)] | [300.7 (214.5)] | [467.0 (386.3)] | |
Median (25th – 75th percentile) | 127,900 (54,800 – 244,700) | 277,300 (150,500 – 447,900) | 258,500 (130,300 – 399,600) | 136,800 (76,700 – 232,000) | 210,600 (103,100 – 349,100) |
[231.5 (99.2–442.9)] | [501.9 (272.4–810.7)] | [467.9 (235.8–723.3)] | [247.6 (138.8–419.9)] | [381.2 (186.6–631.9)] | |
Sum (% of total costs) | 17,317,800 (13.5) | 103,837,600 (35.1) | 51,528,300 (32.7) | 41,200,700 (43.2) | 213,884,400 (31.6) |
[31,347.8] | [187,961.7] | [93,274.0] | [74,579.5] | [387,163.1] | |
Hospitalization | |||||
Mean (SD) | 32,400 (48,700) | 173,100 (212,500) | 240,500 (277,500) | 44,900 (61,500) | 131,300 (200,900) |
[58.6 (88.2)] | [313.3 (384.6)] | [435.3 (502.3)] | [81.3 (111.3)] | [237.7 (363.6)] | |
Median (25th – 75th percentile) | 8000 (4300 – 56,800) | 104,100 (42,600 – 261,400) | 127,800 (28,400 – 379,400) | 26,700 (7000 – 71,000) | 56,800 (11,000 – 161,500) |
[14.5 (7.8–102.8)] | [188.4 (77.1–473.2)] | [231.3 (51.4–686.7)] | [48.3 (12.6–128.5)] | [102.8 (20.0–292.3)] | |
Sum (% of total costs) | 2,982,100 (2.3) | 52,613,900 (17.8) | 39,195,000 (24.9) | 11,144,400 (11.8) | 105,935,400 (15.7) |
[5398.0] | [95,239.1] | [70,948.9] | [20,173.0] | [191,759.1] | |
Physiotherapy | |||||
Mean (SD) | – | 578,400 (503,000) | 401,500 (368,900) | – | 531,500 (475,900) |
[1047.0 (910.5)] | [726.8 (667.7)] | [962.1 (861.4)] | |||
Median (25th – 75th percentile) | – | 408,500 (152,000 – 988,000) | 342,000 (41,300 – 717,300) | – | 389,500 (152,000 – 883,500) |
[739.4 (275.1–1788.4)] | [619.1 (74.8–1298.4)] | [705.0 (275.1–1599.3)] | |||
Sum (% of total costs) | – | 41,645,500 (14.1) | 10,438,500 (6.7) | – | 52,084,000 (7.8) |
[75,384.6] | [18,895.3] | [94,280.0] | |||
Total Costs | |||||
Mean (SD) | 1,395,200 (1,367,000) | 932,700 (675,900) | 815,400 (705,600) | 384,300 (300,500) | 796,100 (777,600) |
[2525.5 (2474.5)] | [1688.3 (1223.5)] | [1476.0 (1277.2)] | [695.6 (543.9)] | [1441.0 (1407.6)] | |
Median (25th – 75th percentile) | 773,400 (432,100 – 2,940,000) | 797,000 (449,700 – 1,258,200) | 611,600 (306,400 – 1,117,400) | 298,100 (180,400 – 526,600) | 571,500 (275,900 – 1,028,100) |
[1400.0 (782.2–5321.8)] | [1442.7 (814.0–2277.5)] | [1107.1 (554.6–2022.6)] | [539.6 (328.4–953.2)] | [1034.5 (499.4–1861.0)] | |
Sum for each CVD and overall | 128,357,700 | 295,662,600 | 157,370,700 | 95,303,300 | 676,694,300 |
[232,346.8] | [535,194.0] | [284,864.8] | [172,513.4] | [1,224,919.1] | |
% of total CVD costs combined | 19.0 | 43.7 | 23.2 | 14.1 | 100.0 |
Costs are in Central African francs (XAF). For ease with comprehension and comparisons, equivalent costs expressed in US dollars are presented in square brackets. CVD Cardiovascular disease, IHD Ischaemic heart disease, I-stroke Ischaemic stroke, H-stroke Haemorrhagic stroke, HHD Hypertensive heart disease, SD Standard deviation